Try our beta test site

Systematic Early Use of Neuromuscular Blocking Agents in ARDS Patients

This study has been completed.
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
Assistance Publique Hopitaux De Marseille
ClinicalTrials.gov Identifier:
NCT00299650
First received: March 6, 2006
Last updated: October 9, 2008
Last verified: October 2008